F YOU REPRESENT inventors of biotechnology inventions, you may need to take another look at the law of conception. In its recent ruling in Hitzeman v. Rutter, 243 F.3d 1345 (Fed. Cir. 2001), the Court of Appeals for the Federal Circuit may have made it harder for inventors in the field of biotechnology to prove a date of conception for their inventions. There has been substantial debate within the biotechnology patent community as to whether the Hitzeman decision actually creates a new standard for conception or simply clarifies the pre-existing law. This article analyzes the extent to which Hitzeman has changed the law and what impact the decision is likely to have.
Law Prior to ‘Hitzeman’
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]
